Casaubon L K, Melanson M, Lopes-Cendes I, Marineau C, Andermann E, Andermann F, Weissenbach J, Prévost C, Bouchard J P, Mathieu J, Rouleau G A
Centre for Research in Neuroscience, Montreal General Hospital Research Institute, Quebec, Canada.
Am J Hum Genet. 1996 Jan;58(1):28-34.
Peripheral neuropathy with or without agenesis of the corpus callosum (ACCPN) is a devastating neurodegenerative disorder that is transmitted as an autosomal recessive trait. Genealogical studies in a large number of affected French Canadian individuals suggest that ACCPN results from a single founder mutation. A genomewide search using 120 microsatellite DNA markers in 14 French Canadian families allowed the mapping of the ACCPN gene to a 5-cM region on chromosome 15q13-q15 that is flanked by markers D15S1040 and D15S118. A maximum two-point LOD score of 11.1 was obtained with the marker D15S971 at a recombination fraction of 0. Haplotype analysis and linkage disequilibrium support a founder effect. These findings are the first step in the identification of the gene responsible for ACCPN, which may shed some light on the numerous conditions associated with the progressive peripheral neuropathy or agenesis of the corpus callosum.
伴有或不伴有胼胝体发育不全的周围神经病(ACCPN)是一种严重的神经退行性疾病,以常染色体隐性遗传特征进行传播。对大量受影响的法裔加拿大个体进行的系谱研究表明,ACCPN是由单一的奠基者突变引起的。在14个法裔加拿大家庭中使用120个微卫星DNA标记进行全基因组搜索,将ACCPN基因定位到15号染色体15q13 - q15上一个5厘摩的区域,该区域两侧为标记D15S1040和D15S118。在重组率为0时,标记D15S971获得了最大两点LOD分数11.1。单倍型分析和连锁不平衡支持奠基者效应。这些发现是鉴定ACCPN致病基因的第一步,这可能为与进行性周围神经病或胼胝体发育不全相关的众多病症提供一些线索。